Matrosovich Mikhail N, Gambaryan Alexandra S
Institute of Virology, Philipps University, Marburg, Germany.
Methods Mol Biol. 2012;865:71-94. doi: 10.1007/978-1-61779-621-0_5.
Influenza virus attachment to sialic acid-containing molecules on the cell surface initiates the infection. The spectrum of functional receptors on target cells and decoy receptors on cells and epithelial mucus varies substantially between animal species leading to variations in the receptor-binding specificity of viruses circulating in these species. Analysis of the receptor specificity of different animal and human influenza viruses can give insight into factors and mechanisms that determine viral host range, tissue and cell tropism, replication efficiency, and pathogenesis. Knowledge of viral receptor specificity may also be useful for the development of more efficient influenza vaccines and anti-influenza drugs.A majority of known receptor specificity assays measure influenza virus binding to sialic acid-containing natural and synthetic compounds (receptor analogues). Here, we describe protocols of two solid-phase enzyme-linked receptor-binding assays which are technically similar to standard ELISA. Each assay determines binding of the virus immobilized in the wells of 96-well plate to receptor analogues in solution. In the direct binding assay, the virus binds to either synthetic biotinylated sialylglycopolymers or to peroxidase-labeled sialylglycoprotein fetuin (Fet-HRP); the apparent association constants of the virus-receptor complexes are calculated from the Scatchard plots of the binding data. In the fetuin-binding inhibition assay, the virus is incubated with a mixture of unlabeled receptor analogue and standard preparation of Fet-HRP; the association constant for analogue is calculated based on the level of its competition with Fet-HRP.
流感病毒附着于细胞表面含唾液酸的分子会引发感染。目标细胞上的功能性受体以及细胞和上皮黏液中的诱饵受体谱在不同动物物种之间存在很大差异,这导致在这些物种中传播的病毒的受体结合特异性有所不同。分析不同动物和人类流感病毒的受体特异性可以深入了解决定病毒宿主范围、组织和细胞嗜性、复制效率及发病机制的因素和机制。了解病毒受体特异性对于开发更有效的流感疫苗和抗流感药物也可能有用。大多数已知的受体特异性检测方法是测量流感病毒与含唾液酸的天然和合成化合物(受体类似物)的结合。在此,我们描述两种固相酶联受体结合检测方法的方案,它们在技术上与标准酶联免疫吸附测定(ELISA)相似。每种检测方法都能确定固定在96孔板孔中的病毒与溶液中受体类似物的结合情况。在直接结合检测中,病毒与合成的生物素化唾液酸糖聚合物或过氧化物酶标记的唾液酸糖蛋白胎球蛋白(Fet-HRP)结合;病毒-受体复合物的表观结合常数根据结合数据的Scatchard图计算得出。在胎球蛋白结合抑制检测中,病毒与未标记的受体类似物和Fet-HRP标准制剂的混合物一起孵育;根据其与Fet-HRP的竞争水平计算类似物的结合常数。